METHOD FOR PREDICTING ACUTE PULMONARY LESION SYNDROME DEVELOPMENT CHANCES IN ACUTE HEMORRHAGE PATIENTS Russian patent published in 2006 - IPC G01N33/48 

FIELD: medicine.

SUBSTANCE: method involves recording and evaluating coagulating blood characteristics like response time r, spontaneous blood platelets aggregation intensity Ar, thrombin constant k, maximum amplitude MA, time required for forming fibrin-and-blood-platelets structure of blood clot T, total retraction and spontaneous clot lysis index F. r=3.19±0.41 min, Ar=-8.20±1.23 rel.units, k=2.57±0.41 min, MA=670.4±39.4 rel.units, T=48.61±7.88 min, F=18.43±1.63% being the case, acute pulmonary lesion syndrome development chance is predicted to be equal to 72.8% among the patients. r=8.76±1.42 min, Ar=-0.44±0.73 rel.units, k=10.52±1.89 min, MA=271.2±68.1 rel.units, T=77.8±10.04 min, F=32.40±6.91% being the case, acute pulmonary lesion syndrome development chance is predicted to be equal to 2.1% among the patients. r=7.26±0.73 min, Ar=-2.13±1.13 rel.units, k=6.84±0.60 min, MA=480.3±56.7 rel.units, T=62.08±2.52 min, F=24.87±4.41% being the case, acute pulmonary lesion syndrome development chance is predicted to be equal to 52.5% among the patients. r=3.53±0.48 min, Ar=-8.69±1.37 rel.units, k=2.60±0.48 min, MA=810.9±54.4 rel.units, T=37.78±3.25 min, F=31.14±3.54% being the case, acute pulmonary lesion syndrome development chance is predicted to be equal to 72.8% among the patients having acute hemorrhage.

EFFECT: high accuracy and descriptive power of data; accelerated process.

1 dwg, 1 tbl